MarketLine Blog

Posts tagged to R&D

Generics Market – Likely To Continue to produce good growth through to 2016

  The global generics market has produced good growth in recent years and, due to the trend of cheaper generics replacing branded pharmaceutical products when patents end, the market is likely to continue to produce good growth through to 2016. The last few years have seen a number of blockbuster drugs coming to the end of their patents, which has shown the speed with which generics can be introduced and dominate a previously locked up market. This change is happening because the switch to generics from branded drugs is highly… Read more